ACE and Myocardial fibrosis: These drugs in combination have synergistic action; for example the combination of an ACE inhibitor, beta-blocker and aldosterone receptor antagonist suppresses myocardial fibrosis in systolic heart failure.3 Therefore, combination therapy with drugs that block the SNS and RAAS systems may be the answer.